Supplementary Figure 1 from Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
crossref（2023）
摘要
PDF file - 565K, Nutlin-3 response in osteosarcoma cell lines. Treated osteosarcoma cells were analyzed by Western blotting and FACS analysis
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要